A classification system for the different stages of aortic stenosis may help clinicians select the right patients for transcatheter aortic valve replacement (TAVR), researchers said.
Based on echocardiographic markers of cardiac function, the staging classification system had a graded association with risk of all-cause mortality even after adjustment for STS-PROM over the study's follow-up period (median 20.1 months):
- Stage 1 (left ventricle damage): reference
- Stage 2 (left atrial or mitral damage): adjusted HR 1.37 (95% CI 0.81-2.31)
- Stage 3 (pulmonary artery or tricuspid damage): adjusted HR 2.24 (95% CI 1.28-3.92)
- Stage 4 (right ventricle damage): adjusted HR 2.83 (95% CI 1.39-5.76)
Those with Stage 3 or 4 disease also had higher odds of cardiac readmissions (HR 1.84, 95% CI 1.13-3.00), reported João Cavalcante, MD, now at Abbott Northwestern Hospital in Minneapolis, and colleagues in JAMA Cardiology.
Researchers who proposed the staging system in 2017 had shown it to be a strong independent predictor of 1-year mortality using PARTNER 2 data.
Now Cavalcante's group confirmed that finding, and showed that staging was linked to all-cause mortality lasting more than a year, as well as associated with post-TAVR readmission.
Their study included 689 consecutive patients with severe aortic stenosis who underwent TAVR at the University of Pittsburgh Medical Center in 2011-2017 (50.9% men; average 82.4), excluding those getting valve-in-valve TAVR. These study participants got a mix of self-expanding (69.1%), balloon-expandable (27.4%), and mechanically expandable valves (3.5%).
Using the staging criteria, Cavalcante and colleagues classified the patients as stage 1 (13%), stage 2 (62%), stage 3 (21%), and stage 4 (4%).
"Whether this proposed staging classification system, bearing its simplifications and limitations, could serve as a framework for monitoring disease progression and making early referral to interventions for patients who start to demonstrate extravalvular cardiac dysfunction will require further study and a larger prospective evaluation," the investigators said.
They noted the limited generalizability of their results given that the study was conducted at a single, high-volume, TAVR center. Additionally, a mix of older- and newer-generation bioprosthetic valves was involved such that outcomes could have been better with later devices.
Cavalcante disclosed support from Medtronic. Co-authors disclosed support from, and relevant relationships with, Medtronic, Edwards Lifesciences, Boston Scientific, and Abbott.
Principles in East Asian Shipbuilding Traditions
bMale Enhancement Safety Guide: Optimizing the Mindb
Article 45 as amended by strongbProblems Affecting The Prostate Glandbstrong the Law of the Republic of Kazakhstan, dated on No 452-IV (shall be enforced from dated. Responsibilities of employers and leaders of organizations to create conditions for donorship development. If there is information about a spouse, close relatives and (or) legal representatives, within forty-eight hours after hospitalization to the psychiatric hospital, the hospitals administration shall inform them about. 504-V (shall be enforced upon expiry of ten calendar days after its first official publication). Treatment for...
The quality and safety bMale Enhancement Safety Guide for Penis Enlargement Trainingb of medicines on pharmaceutical market of the Republic of Kazakhstan shall be established by the requirements of the State Pharmacopoeia of the Republic of Kazakhstan. Dynamic monitoring may be set independently from the consent of a person with a mental disorder bMuscle Building Research and Its Significance to Penis Enlargementb (disease or his legal representative in the cases, specified in paragraph 2 of this Article, and shall include monitoring of the persons mental health. The procedure for development and approval of documents of the state system of sanitary and epidemiological regulation shall be approved by the state body in the field of sanitary and epidemiological welfare of population. The public healthcare sector shall consist of the state healthcare bodies, healthcare organizations, established on the right of the state ownership.